Entrada Therapeutics (TRDA) EBT Margin (2023 - 2026)
Entrada Therapeutics (TRDA) posted quarterly EBT Margin of 4534.74% for Q1 2026, down 445035.0% year-over-year from N/an in Q1 2025, and down 50.76% quarter-over-quarter from 3007.85% in Q4 2025.
Entrada Therapeutics (TRDA) EBT Margin (2023 - 2026) Analysis & Trends
Entrada Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 4534.74% for Q1 2026.
- In Q1 2026, EBT Margin fell 445035.0% year-over-year to 4534.74%; the TTM figure through Mar 2026 stood at 2878.29% (down 289211.0% YoY), while the FY2025 annual figure was 561.84%, down 59338.0% from the prior year.
- EBT Margin for Q1 2026 stood at 4534.74%, down from 3007.85% in the prior quarter.
- The five-year high for EBT Margin was 61.03% in Q2 2024, with the low at 4534.74% in Q1 2026.
- The 4-year median for EBT Margin is 66.49% (2023), against an average of 962.85%.
- The sharpest annual moves came in 2024 and 2026: EBT Margin soared 12752 bps in 2024, then slumped 445035 bps in 2026.
- Entrada Therapeutics' EBT Margin stood at 21.98% in 2023, then tumbled by 109 bps to 1.98% in 2024, then plunged by 152116 bps to 3007.85% in 2025, then sank by 51 bps to 4534.74% in 2026.
- Business Quant data shows TRDA's EBT Margin at 4534.74% in Q1 2026, 3007.85% in Q4 2025, and 2693.93% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - | -4,758.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,758.13% |
| Mar 31, 2026 | -4,534.74% |
| Dec 31, 2025 | -3,007.85% |
| Sep 30, 2025 | -2,693.93% |
| Jun 30, 2025 | -2,201.28% |
| Mar 31, 2025 | -84.39% |
| Dec 31, 2024 | -1.98% |
| Sep 30, 2024 | -81.21% |
| Jun 30, 2024 | 61.03% |
| Mar 31, 2024 | 42.84% |
| Dec 31, 2023 | 21.98% |
| Sep 30, 2023 | 41.30% |
| Jun 30, 2023 | -66.49% |
| Mar 31, 2023 | -12.36% |